Colorifix takes in Series B

Colorifix, a biotech company, has raised 18 million pounds in Series B funding.

1 June 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.